Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ISIS-23722 selected for clinical development

April 24, 2003

Initiation of phase I/II study of CG-7870 plus radiation in early-stage prostate cancer

April 24, 2003

Diatos licenses European rights for Super-Leu-Dox

April 24, 2003

Novel modulators of LPA receptors and their use in cancer, wound healing, etc.

April 24, 2003

Aventis scientists identify novel protein kinase inhibitors

April 24, 2003

Novel tyrosine kinase inhibitors under study at Merck & Co.

April 24, 2003

Three series of antitumor agents prepared and tested at Synta

April 24, 2003

AGI Dermatics regains rights to Dimericine

April 23, 2003

Phase II studies of ILX-651 planned

April 23, 2003

Northwest Biotherapeutics receives NCI grant for tumor growth inhibition

April 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...